Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial

Timothy David Trojan, J. Andrew Bird

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{e004410d82d445a88c47c80cc6a5e7bc,

title = "Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial",

author = "Trojan, {Timothy David} and {Andrew Bird}, J.",

year = "2013",

doi = "10.1542/peds.2013-2294BBBB",

language = "English (US)",

volume = "132",

pages = "S48",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "SUPPL.1",

}

TY - JOUR

T1 - Mepolizumab for severe eosinophilic asthma (DREAM)

T2 - A multicentre, double-blind, placebo-controlled trial

AU - Trojan, Timothy David

AU - Andrew Bird, J.

PY - 2013

Y1 - 2013

UR - http://www.scopus.com/inward/record.url?scp=84885141658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885141658&partnerID=8YFLogxK

U2 - 10.1542/peds.2013-2294BBBB

DO - 10.1542/peds.2013-2294BBBB

M3 - Comment/debate

AN - SCOPUS:84885141658

SN - 0031-4005

VL - 132

SP - S48

JO - Pediatrics

JF - Pediatrics

IS - SUPPL.1

ER -